VCYT Competitors & Alternatives
Compare Veracyte Inc with similar stocks in the same industry
Diagnostics & Research
VCYT
Main Stock$46.22
Tradestie Score
50
Market Cap
$2.85B
P/E Ratio
32.0
Revenue Growth
0.2%
Analyst Upside
+26.4%
Top Competitors
36 stocks in Diagnostics & Research| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
RDNT
RadNet, Inc. Common Stock
|
$68.41
|
$6.00B | - | 73 | Compare |
|
BLLN
BLLN
|
$104.67
|
$4.88B | 164.3 | 49 | Compare |
|
SHC
Sotera Health Company Common Stock
|
$17.77
|
$4.60B | 31.5 | 63 | Compare |
|
WGS
GeneDx Holdings Corp. Class A Common Stock
|
$68.94
|
$3.26B | - | 77 | Compare |
|
GRAL
GRAIL, Inc. Common Stock
|
$132.60
|
$2.24B | - | 55 | Compare |
|
ADPT
Adaptive Biotechnologies Corporation Common Stock
|
$25.33
|
$2.22B | - | 66 | Compare |
|
TWST
Twist Bioscience Corporation Common Stock
|
$149.13
|
$1.77B | - | 58 | Compare |
|
TXG
10x Genomics, Inc. Class A Common Stock
|
$75.59
|
$1.54B | - | 58 | Compare |
|
NEOG
Neogen Corp
|
$11.79
|
$1.26B | - | 61 | Compare |
|
OPK
Opko Health Inc.
|
$1.60
|
$1.23B | - | 51 | Compare |
More VCYT Analysis
Data updated: Oct 21, 2026 | Industry: Diagnostics & Research (SIC 8071)
36 stocks in this industry